Best CorrDyn Podcasts (2025)

1
Jaidev Chakka on building the future of bioprinted medicine 45:24

Play Pause

36m ago45:24

45:24

In this episode of Data in Biotech, Ross Katz chats with Jaidev Chakka, Principal Scientist at the University of Mississippi School of Pharmacy, about how 3D bioprinting and AI are reshaping pharmaceutical manufacturing. They explore the development of custom scaffolds for tissue engineering, the integration of gene delivery systems, and how data-d…

1
From screening to IND: How Veloxity accelerates critical drug decisions 25:34

3d ago25:34

25:34

In this episode of Data in Biotech, Ross Katz sits down with Callie Celichowski and Isa Kupke from Veloxity Labs to discuss how their CRO leverages speed, precision, and innovation to support drug development. Learn how they use mass spectrometry, cloud-based infrastructure, and hands-on client partnerships to drive rapid, high-quality bioanalytica…

1
Revolutionizing bioanalysis with high-resolution mass spec 32:31

10d ago32:31

32:31

In this episode of Data in Biotech, host Ross Katz sits down with Eshani Galermo, Staff Scientist at SCIEX, to explore the next generation of mass spectrometry in pharma and biopharma. Eshani explains how innovations like the ZenoTOF 8600 are redefining sensitivity, selectivity, and workflow efficiency in bioanalytical chemistry. Discover how high-…

1
Mastering solubility and stability in drug development with Serán BioScience 51:14

22d ago51:14

51:14

In this episode of Data in Biotech, Ross Katz chats with Wesley Tatum, Principal Engineer at Serán BioScience, about the intricacies of formulating low-solubility drug products. They explore the science behind amorphous solid dispersions, how data informs formulation choices, and why balancing performance, manufacturability, and stability is critic…

1
Applying ML/AI to Drug Development with Anil Kane 35:48

30d ago35:48

35:48

Dr. Anil Kane, Global Head of Technical & Scientific Affairs at Thermo Fisher Scientific, joins Ross Katz to discuss how AI, machine learning, and digital tools are reshaping drug development. From predictive modeling for formulation to digital manufacturing efficiencies, discover how data-driven approaches are reducing time, cost, and complexity i…

1
Streamlining bioanalytical workflows with Watson LIMS and Thermo Fisher 49:51

1M ago49:51

49:51

In this episode of Data in Biotech, host Ross Katz sits down with John Liberty, Senior Bioanalysis Technical Sales Consultant at Thermo Fisher Scientific. They dive deep into how Watson LIMS™ supports regulated bioanalysis workflows, the evolving role of lab automation, and how Connect Enterprise aims to unify biotech digital ecosystems. What you'l…

1
Scaling AI infra in biotech with Saturn Cloud and Nebius 52:17

2M ago52:17

52:17

Discover how biotech and healthcare teams are fast-tracking research and development through AI and high-performance cloud infrastructure. Ross Katz sits down with Hugo Shi of Saturn Cloud and Ilya Burkov of Nebius to explore scalable, secure solutions for GPU-heavy AI workloads. From compliance to cost savings, this episode unpacks what it takes t…

1
The Future of Co-Folding and Federated Learning with Apheris 49:08

2M ago49:08

49:08

Robin Rohm, CEO and Co-Founder of Apheris, joins Ross Katz to explore how federated learning is unlocking secure, cross-company collaboration in pharma. Discover how Apheris is enabling biopharma leaders to train cutting-edge co-folding models without sharing sensitive data, why AlphaFold 3 wasn’t enough, and what OpenFold 3 means for the future of…

1
Automating biopharma knowledge work with Convoke 56:24

3M ago56:24

56:24

What if biotech teams could automate the most information-intensive parts of bringing a drug to market? In this episode of Data in Biotech, host Ross Katz speaks with Convoke co-founders Alex Telford and Maged Ahmed about building an AI-native knowledge acquisition and curation system for biopharma. Learn how they're transforming clinical research,…

1
How Eli Lilly’s new platform TuneLab codevelops AI models with biotech 40:44

3M ago40:44

40:44

Dr. Aliza Apple, VP of Catalyze360 AI/ML at Eli Lilly, joins Ross Katz to unveil TuneLab—a first-of-its-kind federated learning platform accelerating preclinical drug discovery. Learn how Lilly’s billion-dollar models are empowering early-stage biotechs, the science behind federated learning, and what this means for the future of pharmaceutical R&D…

1
Inside Merck's Computational Biology Approach with Jesper Ryge 46:33

4M ago46:33

46:33

In this episode of Data in Biotech, host Ross Katz talks with Jesper Ryge, Director of Computational Biology at Merck Germany. Jesper shares his journey from neuroscience labs to leading computational teams, offering deep insights into disease modeling, target discovery, and multi-omics integration. Discover how AI and spatial transcriptomics are s…

1
Where Biotech Innovation Really Happens: 50th Episode Special with Wolfgang Halter, Jacob Oppenheim, and Dave Johnson 31:54

4M ago31:54

31:54

To mark our 50th episode, host Ross Katz brings back three visionary leaders—Dave Johnson (Dash Bio), Wolfgang Halter (Merck Life Science), and Jacob Oppenheim (RAVen)—together for a reflection on the evolution of biotech. They unpack the realities behind AI hype, the future of data-driven innovation, and what’s really changing in drug development.…

1
How BioRaptor is Modernizing Bioprocessing Workflows 49:40

5M ago49:40

49:40

In this episode of Data in Biotech, Yaron David, CTO and Co-Founder of BioRaptor, joins host Ross Katz to explore how biotech companies can gain a holistic view of bioprocessing through real-time data integration, visualization, and modeling. Learn how BioRaptor’s full-stack platform helps scientists replace clunky spreadsheets with actionable insi…

1
Modernizing Clinical Data Analysis with Jesse Paquette 45:17

6M ago45:17

45:17

In this episode of Data in Biotech, Jesse Paquette, co-founder and Chief Science Officer of Tag.bio, joins Ross Katz to explore how data mesh architecture and FAIR data principles are transforming clinical and research workflows in life sciences. From harmonizing legacy systems to enabling AI-readiness, Jesse shares how Tag.bio empowers domain expe…

1
Building Scalable Data Platforms for Spatial Biology with Kenny Workman of LatchBio 55:17

6M ago55:17

55:17

In this episode of Data in Biotech, Ross Katz sits down with Kenny Workman, co-founder and CTO of LatchBio, to unpack how biotech’s data infrastructure must evolve to meet the demands of next-gen assays. From scalable workflows to high-performance visualization tools, Kenny breaks down the shift from traditional biotech to a future defined by data-…

1
Solving Chronic Disease with Life Insurance and Data Featuring Jeremy Shane 1:00:25

7M ago1:00:25

1:00:25

Entrepreneur Jeremy Shane joins host Ross Katz to discuss Life for Health, a revolutionary framework aiming to tackle chronic disease through the integration of life insurance, longitudinal data, and preventative care. From drug discovery feedback loops to outcomes-based pricing, Shane outlines a bold new path for biotech and healthcare convergence…

1
How Etiome Is Redefining Preemptive Medicine with Scott Lipnick 58:54

7M ago58:54

58:54

In this episode of Data in Biotech, host Ross Katz sits down with Scott Lipnick, Co-Founder and President of Etiome, to explore how preemptive medicine is changing the way biotech approaches therapeutic modeling and intervention. Discover how Etiome’s recently launched, AI-driven platform is built to detect disease earlier, identify precise biomark…

1
Transforming Houseplants with Synthetic Biology with Patrick Torbey 47:17

8M ago47:17

47:17

In this episode of Data in Biotech, host Ross Katz speaks with Patrick Torbey, CEO and Co-Founder of Neoplants, about using genetic engineering and microbiome innovation to tackle indoor air pollution. Patrick explains how Neoplants is turning everyday houseplants into powerful air purifiers using synthetic biology, offering insights into VOC degra…

1
How Phage Therapy is Scaling to Meet Antibiotic Resistance with Jessica Sacher 59:02

8M ago59:02

59:02

Phage therapy is stepping into the spotlight as antibiotic resistance rises - and Jessica Sacher is helping lead the charge. In this episode, Ross Katz speaks with Jessica, Co-Founder of Phage Directory and Staff Scientist at Stanford, about sourcing phages, operationalizing therapy, and predicting efficacy through data. This conversation explores …

1
Targeting Transcription Factors with AI, featuring Will Fondrie from Talus Bio 46:54

9M ago46:54

46:54

How do you drug the undruggable? In this episode of Data in Biotech, Ross Katz sits down with Will Fondrie, Head of Data Science and Engineering at Talus Bio, to explore how machine learning, mass spectrometry, and innovative computational models are transforming drug discovery. Learn how Talus Bio is targeting transcription factors—once considered…

1
Decoding the Dark Proteome: Biological Insights for Pharma with Dr. Jonathan Usuka from Sapient 46:45

9M ago46:45

46:45

In this episode of the Data and Biotech Podcast, host Ross Katz sits down with Dr. Jonathan Usuka to discuss Usuka’s extensive background in bioinformatics and genomics, leading to his current role as CEO of Sapient. The conversation dives into the importance of deep molecular characterization of diseases, the role of proteomics and metabolomics in…

1
How AI Can Increase Clinical Trial Efficiency with Patrick Leung from Faro Health 39:02

9M ago39:02

39:02

How can AI improve clinical trials and accelerate drug development? In this episode of Data in Biotech, Ross Katz sits down with Patrick Leung, CTO of Faro Health, to explore how AI-driven tools are reshaping clinical trial design. Patrick shares insights into document generation, patient burden analysis, and AI governance in biotech. Learn how Far…

1
Organoids and Active Learning for Chronic Disease with Naren Tallapragada 50:25

10M ago50:25

50:25

In this episode of Data In Biotech, Ross Katz interviews Naren Tallapragada, CEO and Co-founder of Tessel Bio, about his background in electrical engineering and physics and how personal circumstances led to him pivoting his focus to enter biotech and start Tessel Bio. Naren breaks down Tessel Bio’s unique approach to drug discovery, which involves…

1
How Alex Junge from amass is Speeding Up Scientific Breakthroughs with AI 52:25

10M ago52:25

52:25

In this episode of the Data and Biotech Podcast, host Ross Katz sits down with Alexander Junge, Co-Founder and CTO of amass, to break down how AI is reshaping scientific research in life sciences. Alex walks us through how his platform is creating professional tools for researchers, biotech companies, and venture firms to navigate the (rapidly!) gr…

1
Advancing Therapeutic Design in Gene and Cell Therapy with Dipen Sangurdekar 40:34

11M ago40:34

40:34

In this episode of Data in Biotech, Ross sits down with Dipen Sangurdekar, VP of Data Sciences at KSQ Therapeutics, to discuss the role of data-driven approaches in therapeutic design and development. The conversation explores the intersection of computational biology, machine learning, and bioinformatics in advancing personalized medicine and impr…

1
Democratizing Therapeutic Discovery for Neglected Diseases using AI with Timothy Jenkins of DTU Bioengineering 50:39

11M ago50:39

50:39

This week on Data in Biotech, we welcome Timothy Jenkins, the Head of Data Science and Associate Professor at DTU Bioengineering, a leading scientific community dedicated to advancing areas of biotechnology, food technology, and health through innovative teaching and research. Timothy starts the conversation by walking us through his background and…

1
Revolutionizing Drug Discovery with AI: Fred Manby of Iambic Therapeutics 38:19

12M ago38:19

38:19

In this episode, Ross Katz sits down with Fred Manby, Co-Founder and Chief Technology Officer of Iambic Therapeutics, to explore how cutting-edge AI technologies are reshaping the landscape of drug discovery. From building advanced machine learning platforms to designing user-friendly interfaces for scientists, Fred shares insights into the company…

1
Unlocking the Power of AI in Microscopy with Ilya Goldberg and Reese Findley 47:32

1y ago47:32

47:32

In this episode of Data in Biotech, Ross Katz explores the transformative role of AI in microscopic imaging and life sciences with Ilya Goldberg, Chief Science Officer, and Reese Findley, an AI Data Scientist at ViQi. They discuss the cutting-edge applications of AI in automating high-content screening (HCS), enabling more efficient drug discovery,…

1
Reflections & Predictions: One Year of Data in Biotech with Ross Katz 39:42

1y ago39:42

39:42

In this episode of Data in Biotech, Ross Katz reflects on what he’s learned from one year of hosting the podcast. Diving deep into the intersection of data science and biotechnology, this episode covers topics like: The need for predictive models in biotech that are grounded in real-world experimentation. The challenges of biases in model evaluatio…

1
From Moderna to Dash Bio - Revolutionizing Drug Development with Dave Johnson 32:54

1y ago32:54

32:54

In this episode of Data in Biotech, Ross Katz sits down with Dave Johnson, CEO and co-founder of Dash Bio, a next-gen drug development services company with a mission to revolutionize clinical bioanalysis and streamline drug development. Dave begins the episode by taking us back to the early research days in Moderna, where he helped lay the groundw…

1
Chitrang Dave on Harnessing Real-Time Data to Transform MedTech and Healthcare 29:10

1y ago29:10

29:10

This week, Chitrang Dave, Global Head of Enterprise Data & Analytics at Edwards Lifesciences, joins us to discuss the transformative power of real-time data, AI, and collaboration in medical device manufacturing and support. He and host, Ross Katz, dive into how real-time data from IoT devices is reshaping quality assurance in medtech and what the …

1
Automating Bioprocessing to Speed up Workflows with Invert 36:41

1y ago36:41

36:41

This week on Data in Biotech, we’re joined by Martin Permin, the co-founder of Invert, a company that builds software that automates bioprocessing. Martin talks us through his own unique journey into biotech - starting from a role at Airbnb - through to co-founding Invert. Invert helps users grab data from their instruments, map out their individua…

1
The Evolution of Genomic Analysis with Sapient 43:15

1+ y ago43:15

43:15

This week on Data in Biotech, we’re joined by Mo Jain, the Founder and CEO of Sapient, a biomarker discovery organization that enables biopharma sponsors to go beyond the genome to accelerate precision drug development. Mo talks us through his personal journey into the world of science, from school to working in academia to founding his business, S…

1
Transforming Drug Discovery through AI and Single-Cell Multiomics with Cellarity 39:55

1+ y ago39:55

39:55

This week on Data in Biotech, we are joined by Parul Bordia Doshi, Chief Data Officer at Cellarity, a company that is leveraging data science to challenge traditional approaches to drug discovery. Parul kicks off the conversation by explaining Cellarity’s mission and how it is using generative AI and single-cell multiomics to design therapies that …

1
Using Generative AI to Design New Therapeutic Proteins with Evozyne 40:23

1+ y ago40:23

40:23

This week on Data in Biotech, Ryan Mork, Director of Data Science at Evozyne, joins host Ross Katz to discuss how data science and machine learning are being used in protein engineering and drug discovery. Ryan explains how Evozyne is utilizing large language models (LLMs) and generative AI (GenAI) to design new biomolecules, training the models wi…

1
Balancing Software-Driven Processes and Human Curation to Unlock Genomics Intelligence with Genomenon 40:59

1+ y ago40:59

40:59

This week on Data in Biotech, Ross is joined by Jonathan Eads, VP of Engineering at genomics intelligence company Genomenon, to discuss how his work supports the company’s mission to make genomic evidence actionable. Jonathan explains his current role leading the teams focused on clinical engineering, curation engineering, platform development and …

1
Optimizing Allogeneic Cell Therapy Manufacturing with Atara Biotherapeutics 40:00

1+ y ago40:00

40:00

This week on Data in Biotech, we’re joined by Amy Gamber, VP of Manufacturing at Atara Biotherapeutics, an allogeneic T-cell immunotherapy company developing off-the-shelf treatments to help achieve faster patient outcomes. As a treatment that sits at the cutting edge of options available for cancer and autoimmune disease, host Ross Katz explores h…

1
A Look Back on Design of Experiments 55:57

1+ y ago55:57

55:57

It's a holiday week here in the U.S., and the CorrDyn team is currently getting together for our annual company retreat. So, we decided to do something a little different this week. We're re-releasing abridged versions of two of our most popular episodes. These are dedicated to a critical workflow at the intersection of data and scientific research…

1
Giving Biotech Organizations a ‘Digital Brain’ with Scispot 36:56

1+ y ago36:56

36:56

This week on Data in Biotech, we’re delighted to be joined by Guru and Satya Singh, co-founders of SciSpot, a company focused on transforming biotech companies through smarter embodiment of biological processes in data/software and acceleration of the R&D process. They discuss how their respective biotech and data backgrounds led them to develop th…

1
Delivering AI-Driven Drug Development with Generate:Biomedicines 37:00

1+ y ago37:00

37:00

This week, Ross sits down with Mike Nally, CEO at Generate:Biomedicines, a pioneer in generative biology that is transforming the way medicines are developed. Mike joined the Data in Biotech podcast to discuss the AI-driven drug development landscape and how data is set to change the way every drug is made in the future. Mike shares his journey to …

1
Solving Data Integration Challenges in Life Sciences with Ganymede 44:06

1+ y ago44:06

44:06

This week, Nathan Clark, CEO at Ganymede, joins the Data in Biotech podcast to discuss the challenges of integrating lab instruments and data in the biotech industry and how Ganymede’s developer platform is helping to automate data integration and metadata management across Life Sciences. Nathan sits down with Data in Biotech host Ross Katz to disc…

1
The Power of Open-Source Pipelines for Scientific Research with Harshil Patel 41:24

1+ y ago41:24

41:24

This week, Harshil Patel, Director of Scientific Development at Seqera, joins the Data in Biotech podcast to discuss the importance of collaborative, open-source projects in scientific research and how they support the need for reproducibility. Harshil lifts the lid on how Nextflow has become a leading open-source workflow management tool for scien…

1
Improve Quality and Minimize Variability in Biotech Manufacturing with Stewart Fossceco 38:20

1+ y ago38:20

38:20

This week, we are pleased to have Stewart Fossceco, Head of Non-Clinical and Diagnostics Statistics at Zoetis and an expert in pharmaceutical manufacturing, join us on the Data in Biotech podcast. We sat down with Stewart to discuss implementing and improving Quality Assurance (QA) processes at every stage of biotech manufacturing, from optimizing …

1
Delivering on the Promise of Electronic Lab Notebooks with SciNote 43:18

1+ y ago43:18

43:18

This week, we are pleased to welcome to the Data in Biotech podcast Brendan McCorkle, CEO of SciNote, a cloud-based ELN (Electronic Lab Notebook) with lab inventory, compliance, and team management tools. In this episode, we discuss how the priorities of ‘Research’ and ‘Development’ differ when it comes to the data they expect and how they use it, …

1
Developing Future Sustainable Materials Using AI with Cambrium 39:51

2y ago39:51

39:51

This week, we are pleased to be joined on the Data in Biotech Podcast by Pierre Salvy, who recently became the CTO at Cambrium, and his colleague Lucile Bonnin, Head of Research & Development at Cambrium. As part of the Cambrium team behind NovaColl™, the first micro-molecular and skin-identical vegan collagen to market, Pierre and Lucile share the…

1
Building Strong Data Foundations for Biotech Startups with Jacob Oppenheim 42:05

2y ago42:05

42:05

This week, we are pleased to welcome Jacob Oppenheim, Entrepreneur in Residence at Digitalis Ventures, a venture capital firm that invests in solutions to complex problems in human and animal health. Jacob sat down with Ross to discuss the importance of establishing strong data foundations in biotech companies and how to approach the task. We explo…

1
How OmicSoft Is Facilitating In-Depth Exploration Among NGS Datasets 34:44

2y ago34:44

34:44

This week's guest is Joseph Pearson, Global Product Manager of OmicSoft at QIAGEN, a global provider of sample-to-insight solutions that enable customers to gain valuable molecular insights. During this episode, we dive into OmicSoft, a powerful NGS analysis suite that can quickly explore and compare 500,000 curated omics samples from disease-relat…

1
How Bayesian Optimization is Helping to Accelerate Innovation at Merck Group 39:13

2y ago39:13

39:13

This week's guest is Wolfgang Halter, Head of Data Science and Bioinformatics at Merck Life Science, a leading global science and technology company. Ross sat down with Wolfgang to discuss the work on the BayBE project, an open-source library built for Bayesian optimization. Throughout the episode, we go on to learn how BayBE is used for both exper…

1
Transforming Care for Neurological Disorders Through Artificial Intelligence with Annemie Ribbens 48:28

2y ago48:28

48:28

This week, we’re delighted to be joined by Annemie Ribbens, VP Science, Evidence and Trials at icometrix, a medical technology manufacturer that offers a portfolio of AI solutions to assist healthcare with various challenges in neurological disorders, such as brain trauma, strokes, dementia, and Alzheimer's disease. During this episode, Annemie ope…

1
The Applications of Real-World Data in Biotech with Lana Denysyk 34:43

2y ago34:43

34:43

This week, we’re delighted to be joined by Lana Denysyk, Head of RWD Assets at Novo Nordisk. During this conversation, Lana shares how real-world data is used in biotech, diving into how it can help clinicians understand patient experiences outside clinical trials. Lana also discusses the challenges in acquiring and utilising real-world data, the i…